Betmiga 25 mg prolonged-release tablets

Active Ingredient
Strength
  • Mirabegron: 25 mg
Dosage Form
Prolonged-release tablet
Legal Category
B - prescription, may be renewed
Last Updated
25/09/2026
Licence Info section shown.
Licence numbers with strength, ATC code and dosage form
Licence number Strength ATC Code Dosage Form
EU/1/12/809/001 25 mg G04BD Prolonged-release tablet
EU/1/12/809/002 25 mg G04BD Prolonged-release tablet
EU/1/12/809/003 25 mg G04BD Prolonged-release tablet
EU/1/12/809/004 25 mg G04BD Prolonged-release tablet
EU/1/12/809/005 25 mg G04BD Prolonged-release tablet
EU/1/12/809/006 25 mg G04BD Prolonged-release tablet
EU/1/12/809/007 25 mg G04BD Prolonged-release tablet
Licence number
EU/1/12/809/001
Strength
25 mg
ATC Code
G04BD
Dosage Form
Prolonged-release tablet
Licence number
EU/1/12/809/002
Strength
25 mg
ATC Code
G04BD
Dosage Form
Prolonged-release tablet
Licence number
EU/1/12/809/003
Strength
25 mg
ATC Code
G04BD
Dosage Form
Prolonged-release tablet
Licence number
EU/1/12/809/004
Strength
25 mg
ATC Code
G04BD
Dosage Form
Prolonged-release tablet
Licence number
EU/1/12/809/005
Strength
25 mg
ATC Code
G04BD
Dosage Form
Prolonged-release tablet
Licence number
EU/1/12/809/006
Strength
25 mg
ATC Code
G04BD
Dosage Form
Prolonged-release tablet
Licence number
EU/1/12/809/007
Strength
25 mg
ATC Code
G04BD
Dosage Form
Prolonged-release tablet

Astellas Pharma Co. Ltd

Damastown Road, Damastown Industrial Park, Mulhuddart, Dublin 15